ASHP therapeutic position statement on strict glycemic control in patients with diabetes.
The deleterious effects of hyperglycemia have been documented from the biochemical to the pathophysiologic level. Given the research findings and the guidelines for glycemic control established by ADA and ACE, ASHP supports and encourages strict glycemic control in all appropriate patients with diabetes mellitus to reduce the progression of chronic complications.
D001786:Blood Glucose / Q000187:drug effects / Q000378:metabolism*; D002986:Clinical Trials as Topic; D032921:Consensus; D003920:Diabetes Mellitus / Q000188:drug therapy*; D019468:Disease Management; D006801:Humans; D006943:Hyperglycemia / Q000188:drug therapy*; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D012957:Societies, Pharmaceutical
D001786:Blood Glucose; D007004:Hypoglycemic Agents